Skip to main content
. Author manuscript; available in PMC: 2023 Mar 23.
Published in final edited form as: Adv Exp Med Biol. 2022;1395:335–340. doi: 10.1007/978-3-031-14190-4_54

Fig. 2. Weekly treatment with drag reducing polymers (DRP) ameliorates β amyloid plaques deposition formation during Alzheimer’s Disease (AD) development.

Fig. 2

A. Micrograph of thioflavin S stained saline-treated mouse cortex showing no fluorescence at 4 months and B. Bright β-amyloid plaques fluorescence (thioflavin S) at 12 months of AD development. C. Magnified views of the areas outlined in A and B. D. Micrographs with no β-amyloid plaques visible from the second harmonic generation (SHG) signal at 4 months in DRP-treated mouse brain and E. Bright β-amyloid plaques (SHG) signal at 12 months of AD development. F. Graph showing attenuation of b-amyloid plaques deposition in DRP group. Data presented as mean ± SEM, N=10 per group, *p<0.05, white arrows point plaques depositions.